Global Biologics’ Cell & Gene Legal Summit 2023
Global Biologics’ Cell & Gene Legal Summit 2023 addressed recent changes in market circumstances with top industry experts from across the intellectual property, regulatory and commercial fields. Highlights of the summit included understanding the future patent landscape for biologic products and the latest global perspectives on the situation for biologics and biosimilars in Europe, the US and Asia, in addition to analyzing recent trends within the biologics marketplace.
Featured agenda items
Tuesday, June 13, 2023 | 9:10 am CEST
Examine the Latest Regulatory Framework of Biologic and Biosimilar Products
Cooley partner Elizabeth Anne Wright participated in this discussion on the regulatory framework for the commercialization of biologic products.
This industry-led panel addressed the different regulatory pathways for different biologic products and included understanding the impact of the proposed changes to the Pharmaceutical Strategy for Europe on the biopharma industry. The discussion also drew core comparisons between the European clinical trial regulation system and the US system.
Wednesday, June 14, 2023 | 10:10 am CEST
Competition Law: Understand its Role in the Biologic Marketplace
Cooley partner Jonas Koponen participated in this industry-led panel discussion on the crucial legal aspects of the biologics marketplace and the regulatory context of divisional patenting within Europe. In addition, the panel analyzed the European backdrop to M&A law within the biopharma industry, as well as recent regulations affecting the enforcement of competition law within the European Union.
For more information, please email Rebecca Lanz.